Ractigen Therapeutics Reports First-In-Human RNA Activation Data
Shanghai, China, September 16, 2026 Ractigen Therapeutics has announced that it will present first-in-human clinical data from its RNA...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Shanghai, China, September 16, 2026 Ractigen Therapeutics has announced that it will present first-in-human clinical data from its RNA...
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
